Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03CPM
|
||||
Former ID |
DIB001555
|
||||
Drug Name |
SLV-334
|
||||
Indication | Brain injury [ICD10:S09.90] | Phase 2 | [531869] | ||
Company |
Solvay SA
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Neutral endopeptidase | Target Info | Modulator | ||
Endothelin converting enzyme | Target Info | Modulator | |||
NetPath Pathway | EGFR1 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.